Deck Bio
PrivateLast Round
Seed
Apr 9, 2026
Total Funding Raised
$3.1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Deck Bio operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Seed round in April 2026.
Deck Bio is a biotechnology company developing T cell engagers that recognize multiple cancer signals to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Deck Bio Comparables
Compare Deck Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clasp Therapeutics | 87% | |
| Crossbow Therapeutics | 82% | |
| 3T Biosciences | 74% |
For institutional investors. Book with your work email.
Deck Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Deck Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BrightEdge | Seed |
| Mission BioCapital | Seed |
| Impact Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 9, 2026
$3.1M round with Mission BioCapital and BrightEdge
For institutional investors. Book with your work email.
Deck Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Deck Bio's valuation, stock price, and market status.
Is Deck Bio a public or private company?
Deck Bio is a private company.
What is the current stock price of Deck Bio?
Deck Bio is a private company, so its shares have no public market price. Caplight tracks Deck Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Deck Bio worth (valuation)?
Valuation information for Deck Bio is not publicly available.
Can I buy Deck Bio stock?
Deck Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Deck Bio's last funding round?
Deck Bio's most recent funding round was Seed on April 9, 2026.
Who are the main investors in Deck Bio?
Key investors in Deck Bio include BrightEdge, Mission BioCapital, Impact Ventures.
Will Deck Bio IPO soon?
No public IPO plans have been announced for Deck Bio.
How can I track Deck Bio secondary market activity?
Caplight tracks bids, offers, and trades in Deck Bio's shares on secondary markets.